Related Experiment Video
Updated: Mar 1, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Oral Corticosteroid Prescribing for Children With Asthma in a Medicaid Managed Care Program
Harold J Farber1,2,3, Edwin A Silveira4, Douglas R Vicere4
1Section of Pulmonology and hjfarber@texaschildrens.org.
Insights
Oral corticosteroid (OCS) overuse is common in children with asthma, particularly in those aged 1-4 years. Most OCS prescriptions were not associated with indicators of poor asthma control, suggesting overprescribing.
Area of Science:
- Pediatric Pulmonology
- Pharmacology
- Health Services Research
Background:
- Short courses of oral corticosteroids (OCS) are recommended for moderate to severe asthma exacerbations.
- Concerns exist regarding the overuse of OCS in pediatric asthma management.
- Understanding OCS dispensing patterns is crucial for optimizing treatment.
Purpose of the Study:
- To determine the rates of OCS dispensing in children with asthma.
- To identify factors associated with variations in OCS dispensing.
- To assess the appropriateness of OCS prescribing in pediatric asthma.
Main Methods:
- Analysis of claims data from Texas Children's Health Plan for children aged 1 to <18 years with an asthma diagnosis (2011-2016).
- Examination of OCS dispensing rates and associated demographic and clinical factors.
- Comparison of OCS prescribing patterns across different primary care providers and individual pediatricians.
Main Results:
- Between 42.1% and 44.2% of children with asthma received at least one OCS dispensing annually from 2011-2015.
- Younger children (1-4 years) had higher OCS dispensing rates, with frequent repeat dispensing.
- Most OCS dispensings lacked indicators of poor asthma control, and prescribing varied significantly among pediatricians.
Conclusions:
- Observed OCS dispensing patterns indicate substantial overprescribing in children with asthma.
- Targeted interventions may be needed to reduce unnecessary OCS use.
- Further research should explore strategies for appropriate asthma management and OCS stewardship.
Background And Objective:
Short courses of oral corticosteroid (OCS) medication are recommended for treatment of moderate to severe asthma exacerbations. Concern has been raised about OCS overuse. Our objective is to describe rates of OCS dispensing among children with asthma and factors associated with variation in OCS dispensing.
Methods:
Claims data for children 1 to <18 years of age with an asthma diagnosis between January 2011 and January 2016 were extracted from the computerized databases of Texas Children's Health Plan.
Results:
In the years 2011 to 2015, 17.1% to 21.8% of children had an asthma diagnosis. In each of these years 42.1% to 44.2% of these children had ≥1 OCS dispensing. OCS dispensing rates were higher for the children 1 to 4 years of age compared with older children. Repeated OCS dispensing was common, and was most common for children 1 to 4 years of age. Most children with an OCS dispensing (81%-83%) did not have other utilization suggesting poor asthma control (excessive β-agonist refills, emergency department visit, or hospitalization for asthma). OCSs were less commonly prescribed to patients whose primary care provider was a board-certified pediatrician compared with other types of primary care providers. There was large variation in OCS prescribing rates among pediatricians (15%-86%). There were minimal differences in asthma emergency department visits and no differences in hospitalization rates by the pediatrician's OCS dispensing rate quartile.
Conclusions:
The patterns of dispensing observed suggest substantial overprescribing of OCS for children with an asthma diagnosis.
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Inhaled Medications
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-IV: Nursing Management
First, in...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

